<p><em>Waters welcomes back Dr. Ewoud van Tricht where he builds on the last episode when he discussed how Janssen approaches vaccine development with analytical quality by design (AQbD). Today, he elaborates on the specific steps of AQbD and the advantages gained. </em></p>

Waters welcomes back Dr. Ewoud van Tricht where he builds on the last episode when he discussed how Janssen approaches vaccine development with analytical quality by design (AQbD). Today, he elaborates on the specific steps of AQbD and the advantages gained.

Episode 12: Janssen's stepwise approach to AQbD and vaccine development

New guidelines from the USP and ICH will facilitate and accelerate adoption of Method Lifecycle Management (MLCM.) Experts will explore a variety of topics to help you understand and adopt MLCM including: key concepts like the Analytical Target Profile, regulatory changes that will impact your workflow, and case studies exploring the application and advantages of MLCM.

Share Episode 12: Janssen's stepwise approach to AQbD and vaccine development

Sign up to save your podcasts

Episode 12: Janssen's stepwise approach to AQbD and vaccine development

Episode 12: Janssen's stepwise approach to AQbD and vaccine development